Novartis AGNVSNYSE
Loading
Enterprise value to sales ratio
3Y CAGR
+0.9%/yr
vs +4.4%/yr prior
5Y CAGR
+1.1%/yr
Consistent
Acceleration
-3.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.14 | +22.6% |
| 2024 | 4.19 | -12.6% |
| 2023 | 4.80 | -4.1% |
| 2022 | 5.01 | +1.9% |
| 2021 | 4.91 | +0.7% |
| 2020 | 4.88 | +0.9% |
| 2019 | 4.84 | +14.8% |
| 2018 | 4.21 | -6.1% |
| 2017 | 4.49 | +30.8% |
| 2016 | 3.43 | - |